United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

medihealth (northern) ltd - orphenadrine hydrochloride - oral solution - 10mg/1ml

Australia - English - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - orphenadrine citrate, quantity: 100 mg - tablet, modified release - excipient ingredients: ethylcellulose; lactose monohydrate; magnesium stearate; colloidal anhydrous silica - relief of painful muscle spasm associated with fibrositis, whiplash injuries, torticollis, prolapsed intervertebral disc, strains, sprains and similar conditions. has also been shown to be of value in tension headache and persistent hiccup.

United States - English - NLM (National Library of Medicine)

galt pharmaceuticals, llc - orphenadrine citrate (unii: x0a40n8i4s) (orphenadrine - unii:al805o9og9), aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e), caffeine (unii: 3g6a5w338e) (caffeine - unii:3g6a5w338e) - norgesic tm (orphenadrine citrate, aspirin and caffeine 25 mg/ 385 mg/ 30 mg) tablets are indicated in: - symptomatic relief of mild to moderate pain of acute musculoskeletal disorders. - the orphenadrine component is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculoskeletal conditions. the mode of action of orphenadrine has not been clearly identified, but may be related to its analgesic properties. norgesic tm tablets do not directly relax tense muscles in man. because of the mild anticholinergic effect of orphenadrine, norgesic tm tablets should not be used in patients with glaucoma, pyloric or duodenal obstruction, achalasia, prostatic hypertrophy or obstructions at the bladder neck. norgesic tm tablets are also contraindicated in patients with myasthenia gravis and in patients known to be sensitive to aspirin or caffeine. the drug is contraindicated in patients who have demonstrated a previous hypersensitivity to the drug.

Kenya - English - Pharmacy and Poisons Board

orphenadrine citrate paracetamol - tablet - orphenadrine citrate 35 mg/tablet paracetamol 450… - orphenadrine combinations

New Zealand - English - Medsafe (Medicines Safety Authority)

inova pharmaceuticals (new zealand) limited - orphenadrine citrate 100mg - tablet - 100 mg - active: orphenadrine citrate 100mg excipient: colloidal silicon dioxide ethylcellulose lactose monohydrate magnesium stearate - norflex (orphenadrine citrate) is indicated for the relief of stiffness and pain resulting from skeletal muscle spasm in sprains and strains, local muscle injury, prolapsed intervertebral disc, lumbago, fibrositis, non-articular rheumatism, acute torticollis, surgery, fractures, anxiety and tension. orphenadrine citrate has also been shown to be effective for treatment of tension headache and persistent hiccoughs.

United States - English - NLM (National Library of Medicine)

galt pharmaceuticals, llc - orphenadrine citrate (unii: x0a40n8i4s) (orphenadrine - unii:al805o9og9), aspirin (unii: r16co5y76e) (aspirin - unii:r16co5y76e), caffeine (unii: 3g6a5w338e) (caffeine - unii:3g6a5w338e) - orphengesic forte (orphenadrine citrate, aspirin and caffeine 50 mg/ 770 mg/ 60 mg) tablets are indicated in: - symptomatic relief of mild to moderate pain of acute musculoskeletal disorders. - the orphenadrine component is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute painful musculoskeletal conditions. the mode of action of orphenadrine has not been clearly identified, but may be related to its analgesic properties. orphengesic forte tablets do not directly relax tense muscles in man. because of the mild anticholinergic effect of orphenadrine, orphengesic forte tablets should not be used in patients with glaucoma, pyloric or duodenal obstruction, achalasia, prostatic hypertrophy or obstructions at the bladder neck. orphengesic forte tablets are also contraindicated in patients with myasthenia gravis and in patients known to be sensitive to aspirin or caffeine. the drug is contraindicated in patients who have demonstrated a previous h

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

hovid pharmacy sdn. bhd. - paracetamol; orphenadrine citrate -

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

duopharma manufacturing (bangi) sdn bhd - orphenadrine citrate; paracetamol -

Ireland - English - HPRA (Health Products Regulatory Authority)

rosemont pharmaceuticals ltd - orphenadrine - oral solution - 50 mg/5ml

Australia - English - Department of Health (Therapeutic Goods Administration)

inova pharmaceuticals (australia) pty ltd - orphenadrine citrate, quantity: 35 mg; paracetamol, quantity: 450 mg - tablet, uncoated - excipient ingredients: pregelatinised maize starch; colloidal anhydrous silica; microcrystalline cellulose; magnesium stearate; gelatin - tension headache, occipital headaches associated with spasm of skeletal muscles in the region of the head and neck. acute and traumatic conditions of the limbs and trunk: sprains, strains, whiplash injuries, acute torticollis, prolapsed intervertebral disc.